Induction of Immune Response after Allogeneic Wilms’ Tumor 1 Dendritic Cell Vaccination and Donor Lymphocyte Infusion in Patients with Hematologic Malignancies and Post-Transplantation Relapse

Benzer Materyaller

• Factors Predictive of Relapse of Acute Leukemia in Children after Allogeneic Hematopoietic Cell Transplantation
  Yazar:: Shah, Nirali N., ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Donor lymphocyte infusion for relapsed hematological malignancies after allogeneic hematopoietic cell transplantation: prognostic relevance of the initial CD3+ T cell dose
  Yazar:: Bar, Merav, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Disease Detection Methodologies in Relapsed B-Cell Acute Lymphoblastic Leukemia: Opportunities for Improvement
  Yazar:: Shalabi, Haneen, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Impact of cytokine release syndrome on cardiac function following CD19 CAR-T cell therapy in children and young adults with hematological malignancies
  Yazar:: Shalabi, Haneen, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biological Considerations of Hematological Relapse following Allogeneic Stem Cell Transplantation Unrelated to Graft-versus-Tumor Effects: State of the Science
  Yazar:: Cairo, Mitchell S., ve diğerleri
  Baskı/Yayın Bilgisi: (2010)